Phi Pharma competitorsClear all

Phi Pharma's top competitors include Biogen, MyoKardia, Reata Pharmaceuticals and Ironwood Pharmaceuticals.
Phi Pharma
Phi Pharma
Phi Pharma biotherapeutics Company developing peptide drug conjugates.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Founding Date
Founding Date
2012
Founding Date
1978
Founding Date
2012
Founding Date
2002
Founding Date
N/A
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Sion, CH HQ
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
Mississauga, CA
see more
Locations
South San Francisco, US HQ
Locations
Irving, US HQ
Locations
Cambridge, US HQ
Employees
Employees
6
Employees
7,8007% increase
Employees
1024% increase
Employees
12332% increase
Employees
51529% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
44.3 b
Valuation ($)
2.2 b
Valuation ($)
N/A
Valuation ($)
1.7 b
Twitter followers
Twitter followers
N/A
Twitter followers
26.4 k
Twitter followers
619
Twitter followers
672
Twitter followers
3.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
48
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
5
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
24.9
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
2.1
Average likes per tweet (last 30 days)
3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
84.62%
Percentage of tweets with engagement (last 30 days)
60%
Alexa Website Rank
Alexa Website Rank
102363
Alexa Website Rank
83540
Alexa Website Rank
337057
Alexa Website Rank
787661
Alexa Website Rank
977640

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$346.6m (FY, 2018)
Net income
Net income
N/A
Net income
$3.7b (FY, 2016)
Net income
($67.7m) (FY, 2018)
Net income
($80.5m) (FY, 2018)
Net income
($282.4m) (FY, 2018)

Operating

Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
2 (FY, 2017)
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 3.6m
Total funding raised
N/A
Total funding raised
$ 98m
Total funding raised
$ 468.9m
Total funding raised
$ 609m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,800↑ 7% increase

Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Reata Pharmaceuticals
HQ
Irving, US
Employees
123↑ 32% increase

Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
515↓ 29% decrease

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company